A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 418,871 shares of BMRN stock, worth $27.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
418,871
Previous 116,200 260.47%
Holding current value
$27.9 Million
Previous $9.57 Million 207.78%
% of portfolio
0.05%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$69.02 - $93.84 $20.9 Million - $28.4 Million
302,671 Added 260.47%
418,871 $29.4 Million
Q2 2024

Aug 09, 2024

SELL
$74.43 - $92.22 $31.7 Million - $39.3 Million
-425,871 Reduced 78.56%
116,200 $9.57 Million
Q1 2024

May 13, 2024

BUY
$83.81 - $99.0 $13 Million - $15.4 Million
155,400 Added 40.19%
542,071 $47.3 Million
Q4 2023

Feb 13, 2024

SELL
$76.22 - $98.51 $14.9 Million - $19.2 Million
-195,100 Reduced 33.54%
386,671 $37.3 Million
Q3 2023

Nov 14, 2023

SELL
$85.07 - $94.48 $12.8 Million - $14.3 Million
-150,867 Reduced 20.59%
581,771 $51.5 Million
Q2 2023

Aug 11, 2023

SELL
$86.68 - $100.3 $4.2 Million - $4.86 Million
-48,433 Reduced 6.2%
732,638 $63.5 Million
Q1 2023

May 12, 2023

BUY
$87.74 - $117.27 $13.2 Million - $17.7 Million
150,800 Added 23.93%
781,071 $76 Million
Q4 2022

Feb 13, 2023

SELL
$80.93 - $108.63 $9.24 Million - $12.4 Million
-114,200 Reduced 15.34%
630,271 $65.2 Million
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $797,609 - $941,093
9,708 Added 1.32%
744,471 $63.1 Million
Q2 2022

Aug 12, 2022

BUY
$71.48 - $86.85 $17.4 Million - $21.2 Million
243,592 Added 49.59%
734,763 $60.9 Million
Q1 2022

May 13, 2022

SELL
$74.28 - $92.69 $11.9 Million - $14.8 Million
-159,889 Reduced 24.56%
491,171 $37.9 Million
Q4 2021

Feb 11, 2022

BUY
$71.72 - $91.47 $19.3 Million - $24.7 Million
269,589 Added 70.67%
651,060 $57.5 Million
Q3 2021

Nov 12, 2021

BUY
$74.77 - $85.47 $6.84 Million - $7.82 Million
91,500 Added 31.55%
381,471 $29.5 Million
Q2 2021

Aug 13, 2021

SELL
$75.51 - $84.79 $5.71 Million - $6.41 Million
-75,600 Reduced 20.68%
289,971 $24.2 Million
Q1 2021

May 13, 2021

BUY
$74.73 - $90.69 $27.3 Million - $33.2 Million
365,571 New
365,571 $27.6 Million
Q2 2020

Aug 13, 2020

SELL
$79.55 - $124.22 $1.52 Million - $2.37 Million
-19,100 Closed
0 $0
Q1 2020

May 14, 2020

SELL
$71.37 - $96.85 $13.1 Million - $17.8 Million
-183,371 Reduced 90.57%
19,100 $1.61 Million
Q4 2019

Feb 13, 2020

SELL
$64.27 - $86.37 $22.7 Million - $30.5 Million
-353,600 Reduced 63.59%
202,471 $17.1 Million
Q3 2019

Nov 13, 2019

BUY
$67.4 - $85.11 $1.26 Million - $1.59 Million
18,700 Added 3.48%
556,071 $37.5 Million
Q2 2019

Aug 12, 2019

BUY
$80.35 - $93.9 $17.3 Million - $20.2 Million
215,400 Added 66.9%
537,371 $46 Million
Q1 2019

May 14, 2019

BUY
$84.2 - $98.62 $23.4 Million - $27.5 Million
278,400 Added 638.96%
321,971 $28.6 Million
Q4 2018

Feb 13, 2019

BUY
$80.14 - $106.07 $3.49 Million - $4.62 Million
43,571 New
43,571 $3.71 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.